Mario Morales-Orozco
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Trop-2 expression is associated with poor survival in pleural mesothelioma.
Journal: Frontiers in oncology
Published: March 28, 2026
Correction: Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.
Journal: Journal of translational medicine
Published: July 03, 2025
Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma.
Journal: Marine drugs
Published: October 18, 2024
Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.
Journal: Journal of translational medicine
Published: March 25, 2024
Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
Journal: Neurotoxicity research
Published: February 18, 2023
Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA).
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 10, 2023
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: December 05, 2022
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Journal: Thoracic cancer
Published: June 15, 2022
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 18, 2022
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 17, 2022
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: July 26, 2021
Last Updated: 09/26/2026